当前位置:首页 - 行情中心 - 辰欣药业(603367) - 财务分析 - 现金流量表

辰欣药业

(603367)

  

流通市值:65.79亿  总市值:65.79亿
流通股本:4.53亿   总股本:4.53亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,502,638,809.68747,214,773.763,113,315,039.952,408,731,310.2
  收到的税费返还322,196---
  收到其他与经营活动有关的现金208,681,101.4479,887,323.52254,782,413.3206,417,695.22
  经营活动现金流入小计1,711,642,107.12827,102,097.283,368,097,453.252,615,149,005.42
  购买商品、接受劳务支付的现金206,734,077.48128,028,012.25803,042,751.9576,240,178.76
  支付给职工以及为职工支付的现金203,476,143.11102,980,785.59414,983,189.84317,273,900.22
  支付的各项税费175,333,647.481,373,693.95334,185,410.32231,061,331.98
  支付其他与经营活动有关的现金698,964,914.2322,182,627.751,349,511,518.69895,693,453.15
  经营活动现金流出小计1,284,508,782.19634,565,119.542,901,722,870.752,020,268,864.11
  经营活动产生的现金流量净额427,133,324.93192,536,977.74466,374,582.5594,880,141.31
二、投资活动产生的现金流量:
  取得投资收益收到的现金90,784,019.2428,109,094.9153,115,957.56119,739,821.08
  处置固定资产、无形资产和其他长期资产收回的现金净额121,20087,7003,355,581.581,941,000
  收到的其他与投资活动有关的现金3,149,534,016.141,227,534,016.141,359,435,780.13,823,510,038.55
  投资活动现金流入小计3,240,439,235.381,255,730,811.041,515,907,319.243,945,190,859.63
  购建固定资产、无形资产和其他长期资产支付的现金20,823,460.2512,706,277.8764,762,582.2782,066,364.76
  支付其他与投资活动有关的现金3,363,200,0001,790,200,0001,624,965,281.754,774,160,986.58
  投资活动现金流出小计3,384,023,460.251,802,906,277.871,689,727,864.024,856,227,351.34
  投资活动产生的现金流量净额-143,584,224.87-547,175,466.83-173,820,544.78-911,036,491.71
三、筹资活动产生的现金流量:
  取得借款收到的现金--15,344,80015,344,800
  收到其他与筹资活动有关的现金--12,083,833.11-
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--27,428,633.1115,344,800
  偿还债务支付的现金7,473,148.792,107,102.6570,807,780.1868,672,815.15
  分配股利、利润或偿付利息支付的现金74,694,472.9275,847.66185,162,801.43101,953,700.22
  其中:子公司支付给少数股东的股利、利润--2,240,000-
  支付其他与筹资活动有关的现金1,412,382.26-3,418,179.86867,141.34
  筹资活动现金流出小计83,580,003.972,182,950.31259,388,761.47171,493,656.71
  筹资活动产生的现金流量净额-83,580,003.97-2,182,950.31-231,960,128.36-156,148,856.71
四、汇率变动对现金及现金等价物的影响-3,337,736.34-1,416,275.05-793,399.29-713,875.76
五、现金及现金等价物净增加额196,631,359.75-358,237,714.4559,800,510.07-473,019,082.87
  加:期初现金及现金等价物余额1,212,075,732.871,212,075,732.871,120,473,303.891,120,473,303.89
  期末现金及现金等价物余额1,408,707,092.62853,838,018.421,180,273,813.96647,454,221.02
补充资料:
  净利润266,953,312.48-425,618,864.59-
  资产减值准备36,521,281.08-10,186,190.21-
  固定资产和投资性房地产折旧101,770,691.17-190,068,914.4-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧101,770,691.17-190,068,914.4-
  无形资产摊销3,881,243.38-9,025,039.11-
  长期待摊费用摊销393,951.72-471,157.21-
  处置固定资产、无形资产和其他长期资产的损失-10,761.04-707,422.32-
  固定资产报废损失35,923.51-664,130.83-
  公允价值变动损失-30,871,564.66--39,679,633.48-
  财务费用-9,403,290-2,128,986.49-
  投资损失-91,138,677.54--123,468,458.42-
  递延所得税-248,598.98-6,337,254.55-
  其中:递延所得税资产减少-1,143,368.32--923,081.54-
    递延所得税负债增加894,769.34-7,260,336.09-
  存货的减少32,696,796.45-178,690,374.61-
  经营性应收项目的减少-166,503,993.15--102,236,759.86-
  经营性应付项目的增加-61,844,993.75--143,995,589.11-
  其他333,340,779.96--9,342,430.2-
  现金的期末余额1,408,707,092.62-1,180,273,813.96-
  减:现金的期初余额1,212,075,732.87-1,120,473,303.89-
  现金及现金等价物的净增加额196,631,359.75-59,800,510.07-
公告日期2026-08-252026-04-292026-04-032025-10-29
审计意见(境内)标准无保留意见
TOP↑